(Q35753538)

10 August 2017

1 reference

title

Development of secreted proteins as biotherapeutic agents (English)

1 reference

10 August 2017

Angelika L Bonin-Debs

1

1 reference

10 August 2017

Irene Boche

2

1 reference

10 August 2017

Hendrik Gille

3

1 reference

10 August 2017

Ulrich Brinkmann

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

Expert Opinion on Biological Therapy

10 August 2017

1 reference

10 August 2017

4

1 reference

10 August 2017

551-558

1 reference

10 August 2017

4

1 reference

The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment

10 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Erythropoietin improves quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Insulins today and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Virus interference. I. The interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Alpha interferon for induction of remission in hairy-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Advances in therapy for hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Pegfilgrastim: using pegylation technology to improve neutropenia support in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Enhancement of therapeutic protein in vivo activities through glycoengineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Albumin binding as a general strategy for improving the pharmacokinetics of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

Directed evolution of proteins by exon shuffling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.4.551

21 January 2018

Identifiers

DOI

10.1517/14712598.4.4.551

1 reference

10 August 2017

1 reference